11-617704-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_021924.5(CDHR5):c.2185G>A(p.Val729Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000681 in 1,461,308 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021924.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDHR5 | NM_021924.5 | c.2185G>A | p.Val729Ile | missense_variant | 15/15 | ENST00000397542.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDHR5 | ENST00000397542.7 | c.2185G>A | p.Val729Ile | missense_variant | 15/15 | 1 | NM_021924.5 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.000664 AC: 101AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000566 AC: 42AN: 74186Hom.: 0 AF XY: 0.000593 AC XY: 23AN XY: 38806
GnomAD4 exome AF: 0.000683 AC: 894AN: 1309078Hom.: 2 Cov.: 35 AF XY: 0.000697 AC XY: 445AN XY: 638892
GnomAD4 genome ? AF: 0.000663 AC: 101AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000779 AC XY: 58AN XY: 74420
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 07, 2022 | The c.2185G>A (p.V729I) alteration is located in exon 15 (coding exon 15) of the CDHR5 gene. This alteration results from a G to A substitution at nucleotide position 2185, causing the valine (V) at amino acid position 729 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at